PLRX: Contact Levi and Korsinsky if You’re Affected by a Securities Class Action – Active Investigation Underway

Investigation Commenced by Levi & Korsinsky into Pliant Therapeutics, Inc. Regarding Alleged Securities Law Violations On February 25, 2025, Levi & Korsinsky, a prominent securities law firm, announced the initiation of an investigation into Pliant Therapeutics, Inc. (NASDAQ: PLRX) over potential securities law violations. The investigation comes in the wake of the biotech company’s announcement…

Read More

Innovative Industrial Properties Sued: Securities Law Violations Alleged in New Lawsuit Against the Industrial Real Estate Company

Understanding Your Rights as an IIPR Investor: A Comprehensive Guide New York, NY – If you’ve recently experienced losses on your investment in Innovative Industrial Properties, Inc. (IIPR) and are seeking information about potential recovery under the federal securities laws, this article is here to help. In this comprehensive guide, we will walk you through…

Read More

Springbig Announces Acquisition of VICE CRM and New CEO Appointment: Introducing Jaret Christopher

Springbig’s Acquisition of VICE CRM: A Game-Changer in SaaS-Based Marketing Solutions BOCA RATON, Fla., March 17, 2025 – Springbig Holdings, Inc., a pioneering provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs, has recently announced the acquisition of VICE CRM. This AI-enabled performance marketing platform is designed to optimize return on…

Read More

Comparing Vanguard’s High Dividend Yield ETF and Dividend Appreciation ETF: Which is Right for You?

Two Popular Dividend ETFs: Vanguard High Dividend Yield ETF (VYM) and Vanguard Dividend Appreciation ETF (VIG) Investing in exchange-traded funds (ETFs) that focus on dividend-paying stocks can be an excellent strategy for generating consistent income. Two of the most popular dividend ETFs in the market are the Vanguard High Dividend Yield ETF (VYM) and the…

Read More

White House Crypto Summit Boosts Bitcoin: Exploring the Significance of Bitcoin’s Recovery

Bitcoin’s Weekend CME Gap and Upcoming White House Summit: A Double Whammy for Cryptocurrency Enthusiasts The cryptocurrency market has been abuzz with excitement over the past few days, as Bitcoin (BTC) formed a significant gap during the weekend trading session on the Chicago Mercantile Exchange (CME). Meanwhile, the upcoming White House summit on stablecoins, Bitcoin…

Read More

Teva and Medincell’s Exciting News: FDA Greenlights Supplemental Application for Uzedy-R’s Long-Acting Risperidone Injection as a Bipolar Treatment!

Teva Pharmaceuticals and Medincell’s Collaboration: A New Treatment Option for Bipolar I Disorder In a recent press release, Teva Pharmaceuticals, an American subsidiary of Teva Pharmaceutical Industries Ltd., and Medincell, a French biotech company, announced that the supplemental New Drug Application (sNDA) for Uzedy, an extended-release injectable suspension, has been accepted for filing by the…

Read More

Conavi Medical Hires BND Projects Inc. for Corporate Development: A New Partnership for Growth

Conavi Medical Corp. Announces Strategic Partnership with BND Projects Inc. Toronto, Canada, February 4, 2025 – Conavi Medical Corp. (TSXV: CNVI), a leading commercial-stage medical device company specializing in the design, manufacturing, and marketing of imaging technologies for common minimally invasive cardiovascular procedures, is thrilled to announce a new Corporate Development and Strategic Services agreement…

Read More

Mustang Bio Reclaims Nasdaq Listing Compliance after Meeting Minimum Bid Price Requirement

Mustang Bio Regains Compliance with Nasdaq Listing Rule WORCESTER, Mass., Feb. 11, 2025 – Mustang Bio, Inc. (Mustang), a clinical-stage biotechnology company focused on translating today’s medical breakthroughs into tomorrow’s cures for rare and complex diseases, is pleased to announce that it has received notice from The Nasdaq Stock Market LLC (Nasdaq) indicating that the…

Read More